Login to your account

Username *
Password *
Remember Me

The Sygnia Itrix Solactive Healthcare 150 Exchange Traded Fund (ETF) commenced trading on Friday on the Johannesburg Stock Exchange (JSE), providing South African investors with exposure to the healthcare industry across developed markets.

 

This ETF is unique because it is the first to have a sole focus on healthcare and list on the local bourse. The Sygnia Itrix Solactive Healthcare 150 ETF, which has R125 million in funds under management, is a passively managed index-tracking fund listed on the ETF Sector of the JSE. It tracks the performance of Solactive Developed Markets Healthcare 150 Index, which comprises the largest 150 healthcare companies in the developed markets.

Iva Madjarova, Sygnia’s Head of Investing Consulting, said the ETF would bring a two-fold benefit to investors in healthcare. They will potentially earn high returns and contribute to the socio-economic development of societies around the globe. 

 

“The Sygnia Itrix Solactive Healthcare 150 ETF is a low cost and efficient way for South African investors to gain global exposure to the healthcare sector,” said Madjarova.

 

The ETF, which trades under JSE code SYGH, will expand the bourse’s ETF universe, which has grown to 83 listed ETFs with a market capitalisation of R114 billion.

 

Welcoming the listing, Adèle Hattingh, Business Development and Exchange Traded Products Manager at the JSE, said the Sygnia Itrix Solactive Healthcare 150 ETF is opportune because global healthcare is a key focus area now and will continue to be a focus in the future. 

 

“Investing is a long-term undertaking. Looking ahead, investment in medical technology and research to cater for the ever-growing and ageing global population opens up great opportunities for investors,” said Hattingh.